Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
12.33
+0.31 (2.58%)
May 13, 2025, 4:10 PM AEST

Neuren Pharmaceuticals Market Cap

Neuren Pharmaceuticals has a market cap or net worth of 1.50 billion as of May 13, 2025. Its market cap has decreased by -36.82% in one year.

Market Cap
1.50B
Enterprise Value
1.28B
Revenue
216.83M
Ranking
n/a
PE Ratio
11.07
Stock Price
12.33

Market Cap Chart

Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.50B, an increase of 7,090.23%. That is a compound annual growth rate of 23.46%.

History

DateMarket Cap% Change
May 13, 20251.54B-2.78%
Dec 31, 20241.59B-50.04%
Dec 29, 20233.18B217.33%
Dec 30, 20221.00B110.88%
Dec 31, 2021474.89M222.46%
Dec 31, 2020147.27M-40.72%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 113.86B
Pro Medicus 26.55B
Cochlear 17.38B
Sonic Healthcare 12.72B
Ramsay Health Care 8.39B
Telix Pharmaceuticals 8.27B
Ansell 4.61B
Regis Healthcare 2.24B
Market Cap Rankings